Zhihui Lang

1.1k total citations
20 papers, 380 citations indexed

About

Zhihui Lang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Zhihui Lang has authored 20 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Zhihui Lang's work include Peptidase Inhibition and Analysis (4 papers), Cell Adhesion Molecules Research (4 papers) and CAR-T cell therapy research (3 papers). Zhihui Lang is often cited by papers focused on Peptidase Inhibition and Analysis (4 papers), Cell Adhesion Molecules Research (4 papers) and CAR-T cell therapy research (3 papers). Zhihui Lang collaborates with scholars based in United States, United Kingdom and France. Zhihui Lang's co-authors include Christopher G. Murlas, Stephan Ladisch, Michael F. Guerrera, Gordon C. Jayson, Hugh M. Davis, G. Williams, Robert A. Beckman, M. Trikha, Jeffrey A. Nemeth and Marian T. Nakada and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Biochemical and Biophysical Research Communications.

In The Last Decade

Zhihui Lang

20 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhihui Lang United States 12 155 98 95 66 64 20 380
Gülden Dınız Türkiye 12 193 1.2× 44 0.4× 62 0.7× 45 0.7× 57 0.9× 78 457
Anandarup Gupta United States 10 244 1.6× 36 0.4× 61 0.6× 28 0.4× 56 0.9× 11 395
Bettine A.H. Vosse Netherlands 9 132 0.9× 52 0.5× 121 1.3× 201 3.0× 60 0.9× 16 414
Leslie A. Caromile United States 11 163 1.1× 25 0.3× 73 0.8× 85 1.3× 40 0.6× 16 358
B. Mainprice France 8 149 1.0× 53 0.5× 61 0.6× 104 1.6× 116 1.8× 9 426
Isaac Rosa Spain 14 288 1.9× 31 0.3× 63 0.7× 61 0.9× 45 0.7× 20 556
Vincenzo Ciocca United States 8 156 1.0× 63 0.6× 82 0.9× 242 3.7× 245 3.8× 12 508
Minyi Gu United States 5 156 1.0× 48 0.5× 28 0.3× 34 0.5× 56 0.9× 7 416
Kerrie Wilson United Kingdom 8 147 0.9× 26 0.3× 119 1.3× 80 1.2× 153 2.4× 10 473
Rosalind C. Williamson United Kingdom 11 262 1.7× 93 0.9× 34 0.4× 52 0.8× 151 2.4× 17 505

Countries citing papers authored by Zhihui Lang

Since Specialization
Citations

This map shows the geographic impact of Zhihui Lang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhihui Lang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhihui Lang more than expected).

Fields of papers citing papers by Zhihui Lang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhihui Lang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhihui Lang. The network helps show where Zhihui Lang may publish in the future.

Co-authorship network of co-authors of Zhihui Lang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhihui Lang. A scholar is included among the top collaborators of Zhihui Lang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhihui Lang. Zhihui Lang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Coleman, Ruth L., et al.. (2019). Meta-analysis of the impact of alpha-glucosidase inhibitors on incident diabetes and cardiovascular outcomes. Cardiovascular Diabetology. 18(1). 135–135. 21 indexed citations
2.
Cookson, Michael S., Sam S. Chang, Christine Lihou, et al.. (2014). Use of intravesical valrubicin in clinical practice for treatment of nonmuscle-invasive bladder cancer, including carcinoma in situ of the bladder. Therapeutic Advances in Urology. 6(5). 181–191. 36 indexed citations
3.
Tóth, Ervin, et al.. (2012). PUK16 Cost-Effectiveness of Ketosteril Treatment in Stage 3-4 CKD Patients. Value in Health. 15(7). A458–A458. 1 indexed citations
5.
O’Day, Steven, Anna C. Pavlick, Mark R. Albertini, et al.. (2011). Clinical and pharmacologic evaluation of two dose levels of intetumumab (CNTO 95) in patients with melanoma or angiosarcoma. Investigational New Drugs. 30(3). 1074–1081. 22 indexed citations
8.
Nemeth, Jeffrey A., Marian T. Nakada, M. Trikha, et al.. (2007). Alpha-v Integrins as Therapeutic Targets in Oncology. Cancer Investigation. 25(7). 632–646. 81 indexed citations
9.
Manges, Robert, Heather J. Sutherland, Sundar Jagannath, et al.. (2007). Preliminary Results of CNTO 328, an Anti-Interleukin (IL)-6 Monoclonal Antibody (mAb), in Combination with Bortezomib in the Treatment of Relapsed or Refractory Multiple Myeloma.. Blood. 110(11). 1183–1183. 3 indexed citations
10.
Chu, Franklin, et al.. (2007). Phase I study of CNTO 95, a fully human monoclonal antibody to αv integrins, docetaxel, and prednisone in hormone refractory prostate cancer patients (HRPCP). Journal of Clinical Oncology. 25(18_suppl). 15595–15595. 1 indexed citations
11.
Jayson, Gordon C., Saifee Mullamitha, Christopher Ton, et al.. (2005). Phase I study of CNTO 95, a fully human monoclonal antibody (mAb) to αv integrins, in patients with solid tumors. Journal of Clinical Oncology. 23(16_suppl). 3113–3113. 12 indexed citations
12.
Lang, Zhihui, Patricia A. Dinndorf, Stephan Ladisch, Eliel Bayever, & Gregory H. Reaman. (2004). Chromosomal transformation in donor cells following allogeneic bone marrow transplantation. Bone Marrow Transplantation. 33(12). 1253–1256. 14 indexed citations
13.
Lang, Zhihui, et al.. (2001). Ganglioside GD1a Enhances VEGF-Induced Endothelial Cell Proliferation and Migration. Biochemical and Biophysical Research Communications. 282(4). 1031–1037. 50 indexed citations
14.
Lang, Zhihui & Jay Feingold. (1996). An autonomously replicating eukaryotic expression vector with a tetracycline-responsive promoter. Gene. 168(2). 169–171. 12 indexed citations
15.
Murlas, Christopher G., et al.. (1993). Dexamethasone reduces tachykinin but not ACh airway hyperreactivity after 03. Lung. 171(2). 109–121. 11 indexed citations
17.
Lang, Zhihui & Christopher G. Murlas. (1992). Neutral Endopeptidase of a Human Airway Epithelial Cell Line Recovers after Hypochlorous Acid Exposure: Dexamethasone Accelerates This by Stimulating Neutral Endopeptidase mRNA Synthesis. American Journal of Respiratory Cell and Molecular Biology. 7(3). 300–306. 18 indexed citations
18.
Murlas, Christopher G., et al.. (1992). Aerosolized neutral endopeptidase reverses ozone-induced airway hyperreactivity to substance P. Journal of Applied Physiology. 72(3). 1133–1141. 30 indexed citations
19.
Lang, Zhihui & Christopher G. Murlas. (1991). HOCl exposure of a human airway epithelial cell line decreases its plasma membrane neutral endopeptidase. Lung. 169(1). 311–323. 8 indexed citations
20.
Murlas, Christopher G., et al.. (1990). HOCl causes airway substance P hyperresponsiveness and neutral endopeptidase hypoactivity. American Journal of Physiology-Lung Cellular and Molecular Physiology. 258(6). L361–L368. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026